Page last updated: 2024-12-07
fenclorim
Description
Fenclorim is a fungicide that inhibits the biosynthesis of ergosterol, a vital component of fungal cell membranes. This compound is known to be effective against a wide range of fungal diseases in various crops. Its synthesis involves a multi-step process that includes reactions like nitration, chlorination, and acylation. Due to its agricultural importance and environmental impact, studies are conducted to assess its efficacy, understand its mode of action, and explore potential alternatives. Fenclorim is studied for its potential to control fungal diseases in crops, leading to increased crop yield and reduced economic losses. Studies also aim to evaluate its environmental fate and potential risks to non-target organisms.'
fenclorim: an herbicide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 77338 |
| CHEMBL ID | 2447919 |
| CHEBI ID | 81993 |
| SCHEMBL ID | 126683 |
| MeSH ID | M0486282 |
Synonyms (39)
| Synonym |
|---|
| brn 0142293 |
| cga-123407 |
| fenclorime |
| nsc 27713 |
| pyrimidine, 4,6-dichloro-2-phenyl- |
| fenclorim [iso] |
| fenclorim |
| 53665t9bhj , |
| 5-23-08-00007 (beilstein handbook reference) |
| unii-53665t9bhj |
| 3740-92-9 |
| nsc27713 |
| nsc-27713 |
| 4,6-dichloro-2-phenylpyrimidine |
| AC-907/34127043 |
| AKOS002665247 |
| C18832 |
| CHEMBL2447919 |
| chebi:81993 , |
| F0851 |
| FT-0603648 |
| 1J-330S |
| AM20060990 |
| 4,6-dichloro-2-phenyl pyrimidine |
| 4,6-dichloro-2-phenyl-pyrimidine |
| SCHEMBL126683 |
| 4,6-dichloro-2-phenylpyrimidine - |
| W-202538 |
| AC-24777 |
| DTXSID90190843 |
| mfcd00754193 |
| fenclorim, pestanal(r), analytical standard |
| Q3068335 |
| CS-W013048 |
| SY046993 |
| SB60675 |
| 2-phenyl-4,6-dichloropyrimidine |
| EN300-128072 |
| Z1140391397 |
Research Excerpts
Overview
Fenclorim is a safener developed for pretilachlor (Pre) It can protect rice from injury caused by Pre but does not lower the weed control effects of Pre.
Drug Classes (2)
| Class | Description |
|---|
| pyrimidines | Any compound having a pyrimidine as part of its structure. |
| organohalogen compound | A compound containing at least one carbon-halogen bond (where X is a halogen atom). |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 31.97
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 31.97 (24.57) | | Research Supply Index | 2.40 (2.92) | | Research Growth Index | 4.66 (4.65) | | Search Engine Demand Index | 37.86 (26.88) | | Search Engine Supply Index | 2.11 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |